| Name | Paper | Description of Comparison | Gene | RSID | Association | Disease Status | MAF | Statistical Odds Ratio | Statistical P-value |
| Horowitz_rs2109069 | Common genetic variants identify therapeutic targets for COVID-19 and individuals at high risk of severe disease | Meta analysis, External data | DPP9 | rs2109069 | Positive | Severe | 0.31 | 1.06 | 0.0001 |
| Pairo-Castineira_rs2109069 | Genetic mechanisms of critical illness in Covid-19 | Critical COVID vs controls UKB | DPP9 | rs2109069 | Positive | Critical | None | 1.4 | 0.000000000004 |
| Pairo-Castineira_rs2109069 | Genetic mechanisms of critical illness in Covid-19 | hospitalised vs controls | DPP9 | rs2109069 | Positive | Severe | None | 1.2 | 0.0000000000007 |
| COVID-19 HGI_rs2109069 | Mapping the human genetic architecture of COVID-19 | Hospitalised vs Controls | DPP9 | rs2109069 | Positive | Severe | 0.312 | 1.154 | 0.0000000000000000276 |
| COVID-19 HGI_rs2109069 | Mapping the human genetic architecture of COVID-19 | Critical vs Controls | DPP9 | rs2109069 | Positive | Critical | 0.316 | 1.26 | 0.000000000000000000000968 |
| Li_rs2109069 | Genome-wide association study of COVID-19 severity among the Chinese population | severe vs control (Huoshenshan cohort) | DPP9 | rs2109069 | positive | Severe | None | 1.33 | 0.032 |
| Horowitz_2_rs2109069 | Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease | Hospitalised COVID-19 vs negative/unknown | DPP9 | rs2109069 | positive | Susceptibility | 31.0 | 1.1 | 0.0000003 |
| Horowitz_2_rs2109069 | Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease | COVID-19 hospitalised vs not hospitalised | DPP9 | rs2109069 | positive | Severe | None | 1.08 | 0.000566 |
